Philip Smalley has joined Wamberg Genomic Advisors as its chief medical director. An internal medicine specialist, Smalley will be responsible for WGA's medical research. Prior to joining the firm, he served as senior vice president and global chief medical officer for RGA International. He also served as managing director of the Longer Life Foundation, an RGA/Washington University in St. Louis partnership that funds research on the determinants of longevity and promoting quality and quantity of life. Smalley received his medical degree from the University of Toronto, after which he practiced and taught medicine at a University of Toronto-affiliated teaching hospital. He is a fellow of the Royal College of Physicians and Surgeons of Canada and past president of the Canadian Life Insurance Medical Officers Association.